Awesome work @NakashimaJustyn! One of our chiefs @MoffittRadOnc soon to provide excellent care to many patients in the Orlando area 💪🏻
From #ASTRO25 : Justyn Nakashima, DO (@NakashimaJustyn) shares institutional outcomes of SBRT for extracranial oligometastatic renal cell carcinoma during the poster Q&A.
Results indicate that SBRT is safe and effective, delaying systemic therapy while maintaining high LC and PFS.
#MoffittASTRO25
Strong 💪🏻 work from a stellar resident @celinachiodo presenting @MoffittNews early experience with online hypofx adaptive bladder radiation. Awesome support by @MoffittRadOnc physics in making this an option for our patients
Great job @DK_18621 presenting your research on the use of ctDNA in post-TMT surveillance. Much to learn with this data. 🚨 Rising ⭐️ @MoffittRadOnc @MoffittNews
Strong work @ninaobertopp & @MoffittNews Pilon-Thomas lab on how 8 Gy x 1 may open options for RT-cellular therapy integration! @MoffittRadOnc @RRS_RadRes @QuadShotNews
Local Single-Dose Radiation Improves Adoptive Cell Therapy With Tumor-... sciencedirect.com/science/ar…
Received this letter today. Extremely honored to join this laser-focused group of clinicians/scientists/advocates that work tirelessly to eradicate #bladdercancer. Much to learn & much to do for our patients. Thank you @IBCG_BladderCA for the opportunity.
1/n @MoffittNews experience in small cell/NE bladder cancer. Project led by former @MoffittRadOnc chiefs @LiveringhouseCL (now in N. Dakota) @A_CT_SimMDJD (The Ohio St) and @LaurenLinkowski (U Penn rad onc resident).See paper at authors.elsevier.com/c/1js1A…
Congrats @UrogerliMD. Your tireless efforts are paying off for bladder patients. Keep it up 💪🏻
Final results of #CORE001 trial out now @NatureMedicine (1/14)
35 pts with BCG-UR CIS treated w/ Creto + pembro
👉12mo CR (per RBB) = 57.1% (ITT)
👉24mo CR = 54% *(Auth Corr)
👉No patient progressed to MIBC
👉No synergistic toxicity
@garysteinbergmd
nature.com/articles/s41591-0…
1
5
571
1/n: Are you interested in the surfaceome profile in penile ca (PSCC), then look no further. First attempt to describe this in our recent paper w/ @spiess @JadChahoud @gatechatl @biodataguy @r_rogatto and others @MoffittResearch
mdpi.com/2072-6694/15/14/363…
Great work @gatechatl and team!
Fresh off the press. PATH‑SURVEYOR: pathway level survival enquiry for immuno‑oncology and drug repurposing rdcu.be/dfCGf Congrats to Alyssa Obermayer and coauthors @ATarhiniMDPhD @xuefwang @gdgrass @DarwinChangZ @MoffittResearch @BMCBioinfo
176
Leading the charge @UrogerliMD one day at a time to do better for our #bladdercancer patients. #Righttreatment4rightpatient
Can a Urine Test Change the Standard of Care for Bladder Cancer? | Moffitt moffitt.org/endeavor/archive…
1
3
748
Thanks for sharing your amazing talent @julian_lage and trio last night @CenterStageAtl Truly masterful performance.
Watch out #radonc @LaurenLinkowski is a rising super ⭐️. Great job!
This Post is from an account that no longer exists. Learn more
Great meeting! Lots of cross-disciplinary innovation happening. #momentum to do better for our patients.
This Post is from an account that no longer exists. Learn more
1/n: TWEETORIAL - on our work in @ASTRO_org #RedJournal relating immune contexture & #radiation sensitivity in >10k primary tumors. HUGE efforts by @HeikoEnderling @jc_atlantis @jtorresroca @KAhmedMD @DrJamesMule & more @MoffittRadOnc @MoffittNews link -> https://teapawt.org/t.co/4jyZmtxu1B
Interesting #GU22 abstract. No severe tox seen with hypofx RT to bladder with IO. Clearly more to learn about this combo
3
Interim analysis of multi-site (@HuntsmanCancer & @MoffittNews) ph 2 NEXT trial (TMT -> adjvnt nivo) @ASCO #GU22 Great collab w/ @SumatiNysumi. Strong #multiDcare w/@UrogerliMD @michael_poch @rohitjainMD for high risk #bladdercancer pts. Much more to learn @BladderCancerUS
First multi-D bladder cancer clinic @MoffittNews with @LoganZemp. Working together to improve #Bladdercancer care for our patients - right treatment for the right patient. @MoffittRadOnc @MoffittGUOnc grateful for support of @JulioPowSangMD @michael_poch @KOSJ12 @sgilbert1973
Well done @HeikoEnderling @EnderlingLab
4
BRAVOS!!!! #ForTheA FOR LIFE!! CONGRATS! AGAINST TONS OF ADVERSITY, <.500 @ MID SEASON...PERSEVERANCE, CHARACTER, TALENT, SWEAT & TEARS. 22 YEARS AGO WAS THE LAST TIME WE SAW THIS CHANCE. SO HAPPY!!
4
















